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AhrC and Eep Are Biofilm Infection-Associated Virulence Factors in
Enterococcus faecalis
Kristi L. Frank,a Pascale S. Guiton,b* Aaron M. T. Barnes,a Dawn A. Manias,a Olivia N. Chuang-Smith,a* Petra L. Kohler,a*
Adam R. Spaulding,a* Scott J. Hultgren,b Patrick M. Schlievert,a* Gary M. Dunnya
Department of Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota, USAa; Department of Molecular Microbiology and Microbial Pathogenesis,
Washington University School of Medicine, St. Louis, Missouri, USAb
Enterococcus faecalis is part of the human intestinal microbiome and is a prominent cause of health care-associated infections.
The pathogenesis of many E. faecalis infections, including endocarditis and catheter-associated urinary tract infection (CAUTI),
is related to the ability of clinical isolates to form biofilms. To identify chromosomal genetic determinants responsible for E.
faecalis biofilm-mediated infection, we used a rabbit model of endocarditis to test strains with transposon insertions or in-frame
deletions in biofilm-associated loci: ahrC, argR, atlA, opuBC, pyrC, recN, and sepF. Only the ahrCmutant was significantly atten-
uated in endocarditis. We demonstrate that the transcriptional regulator AhrC and the protease Eep, which we showed previ-
ously to be an endocarditis virulence factor, are also required for full virulence in murine CAUTI. Therefore, AhrC and Eep can
be classified as enterococcal biofilm-associated virulence factors. Loss of ahrC caused defects in early attachment and accumula-
tion of biofilm biomass. Characterization of ahrC transcription revealed that the temporal expression of this locus observed in
wild-type cells promotes initiation of early biofilm formation and the establishment of endocarditis. This is the first report of
AhrC serving as a virulence factor in any bacterial species.
The role of biofilms in the pathogenesis of infectious diseaseshas received significant attention over the past decade (1, 2).
Microbial biofilm infections are the result of a complex interplay
between surface-associated microbes embedded in an extracellu-
larmatrix and attempts by the host immune defenses to clear these
often chronic infections (3). Biofilm infections occur throughout
the human body on both native and implanted prosthetic surfaces
(4). Animal models to study biofilm infections experimentally are
as abundant as the types of infections and the bacteria that cause
them (5). Likewise, the plethora of experimental approaches used
to define the genetic determinants of biofilm formation in patho-
genic bacteria with in vitro assays are too numerous to cite here.
There remains, however, a paucity of knowledge on the relation-
ship between the genetic basis of in vitro biofilm formation and
virulence in biofilm infections.
Enterococcus faecalis, a Gram-positive constituent of the hu-
man intestinal microbiome, has become a prominent pathogen of
health care-associated infections (HAIs) over the past 3 decades.
Between 1980 and 2008, the frequency of HAIs caused by E. faeca-
lis and Enterococcus faecium, the other frequently encountered
enterococcal pathogen, increased by 8.8% (6). E. faecalis and E.
faecium infections together accounted for 16.0% of central line-
associated bloodstream HAIs, 14.9% of catheter-associated uri-
nary tract HAIs, and 11.2% of surgical site HAIs reported to the
United States National Healthcare Safety Network in 2006 and
2007 (7). E. faecalis is also the primary causative agent of entero-
coccal endocarditis (8, 9), an infection of the heart valves, which is
the second leading cause of infective endocarditis in North Amer-
ica and the fourth worldwide (10). Enterococcal endocarditis is
more prevalent than nonenterococcal endocarditis in cancer pa-
tients and is associated with an overall mortality rate of 11 to 22%
(8, 9).
Biofilm formation on the surfaces of medically implantable
prosthetic devices (e.g., central lines and urinary catheters) or host
tissues (e.g., damaged heart valves) underlies the pathogenesis of
most enterococcal infections (11). Established animal models of
endocarditis and urinary tract infection (UTI), which both man-
ifest from biofilm etiologies, have been used to study E. faecalis
virulence (12–16). E. faecalis hasmultiple surface proteins, such as
Ebp pili and Ace, that act as adhesins to bind to host cells and
proteins, which resultantly promotes in vitro biofilm formation
and virulence in models of endocarditis and UTI (11). Recently,
we reported that Eep, an intramembrane protease, is also an en-
docarditis virulence factor (13). While an eep in-frame deletion
mutant can attach to surfaces and form biofilms in vitro, we
showed that early stage biofilms formed by this strain have an
altered cell distribution phenotype.We further demonstrated that
the endocarditis attenuation phenotype could be successfully
complemented in vivo by expression of eep from a plasmid that
was lost from the majority of bacteria during the course of the
experimental infection. These data support the hypothesis that
Eep is also important during early heart valve infection (13).How-
ever, the contribution of Eep to other biofilm infections and its
function in enterococcal pathogenesis remain unknown.
E. faecalis OG1RF is a well-characterized strain that has dem-
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onstrated virulence in animal models despite lacking the plasmids
andmobile genetic elements known to harbor classical enterococ-
cal virulence factors and antibiotic resistance genes (17, 18). Con-
served genes in OG1RF are likely to be present in the genomes of
other pathogenic E. faecalis strains (19), which makes the strain
particularly useful for studying the biological contributions of
chromosomal genes in the absence of extraneous chromosomal or
extrachromosomal genetic elements. Our group previously
screened an OG1RF random mini-mariner transposon insertion
library containing approximately 15,000 clones to identify genetic
determinants in the E. faecalis core genome that are necessary for
biofilm formation in a standard microtiter plate biofilm assay
(20). Ten distinct biofilm-associated loci were identified from 25
biofilm-defective transposon insertion mutants. Of these, srtA,
coding for the housekeeping sortase, and the ebp pilus genes and
their associated sortase gene, srtC, have also been implicated in
enterococcal virulence (12, 16, 21, 22). In contrast, disruption of
the major autolysin gene (atlA), an important mediator of DNA
release during biofilm formation in vitro (23), did not result in
reduced virulence in either peritonitis (24) or catheter-associated
urinary tract infection (12). To the best of our knowledge, the
other seven loci have not been studied directly in virulence mod-
els. We also used recombinase-based in vivo expression technol-
ogy (RIVET) to identify promoters that are upregulated in E.
faecalis OG1RF during in vitro biofilm growth (25). No common
genes were found between the transposon and biofilm RIVET
screens, but the screens were complementary in that there were
four genomic regions with two adjacent genes where one gene was
identified in the RIVET screen and the other genewas identified in
the transposon screen. Two genes with transposon insertions en-
code transcriptional regulators, suggesting the possibility of regu-
latory interactions between these and the adjacent genes that were
identified in the RIVET screen (25).
The ability to form biofilms is common among E. faecalis iso-
lates of clinical origin (26, 27), but a broad analysis to identify the
genetic loci on the E. faecalis chromosome that are responsible for
biofilm-associated infection has not been undertaken. We postu-
lated that screening the potential biofilm determinants identified
in our previous genetic screens for roles in virulence in an animal
model of biofilm infection would lead to the discovery of new
biofilm-associated virulence factors. Therefore, the purpose of
this study was to identify biofilm formation genes in E. faecalis
OG1RF that contribute to the pathogenesis of endocarditis. To
that end, we tested whether five of the biofilm-defective trans-
poson insertionmutants (20) were attenuated in a rabbitmodel of
endocarditis. In addition, we sought to test whether the comple-
mentary outcome of the combined results of our previous trans-
poson and RIVET screens predicted regulatory interactions
among biofilm-associated genes (25). To do this, we characterized
the biofilm formation and endocarditis virulence phenotypes of
two strains with in-frame deletions of genes identified in our
RIVET screen that are adjacent to the two biofilm-associatedArgR
family transcriptional regulators identified in the transposon
screen. We show here that the E. faecalis ortholog of the ArgR
family transcription factor AhrC is an important early biofilm
gene product that is necessary for endocarditis virulence. Our data
further reveal that AhrC andEep, the endocarditis virulence factor
we recently identified (13), are also important for virulence in an
experimental biofilm infection model of catheter-associated UTI.
Overall, the data presented in this study demonstrate that novel
virulence factors with important in vivo functions can be identi-
fied from in vitro functional screens.
MATERIALS AND METHODS
Bacterial strains, growth conditions, and chemicals. E. faecalis strains
used in this study are listed in Table 1. E. faecalis was routinely cultivated
in brain heart infusion broth (BHI) (BD Bacto; Becton, Dickinson and
Company, Sparks, MD) or on BHI agar under static conditions at 37°C in
ambient air. Cultures for endocarditis experiments were grown in
trypsinized beef heart dialysate (BH) medium (28) under static con-
ditions at 37°C with 7% CO2. Tryptic soy broth without added dextrose
(TSB-dex; Becton, Dickinson, and Company) was used for biofilm assays.
M9-YE glucose medium (29) was used to grow cells for Western blot
experiments. Escherichia coli strains DH5 and EC1000 were used for
plasmid construction and propagation and were grown in LB and BHI,
respectively. Antibiotics were added as necessary to select and maintain
plasmids.
Nisin, erythromycin, carbenicillin, and kanamycin were purchased
from Sigma-Aldrich (St. Louis, MO). Stock solutions of nisin at 25g/ml
in water, erythromycin at 50 mg/ml in methanol, carbenicillin at 50
mg/ml in water, and kanamycin at 100mg/ml in water were prepared and
stored at20°C. All restriction enzymes were purchased from New Eng-
land BioLabs (Ipswich,MA). PfuUltra II fusionDNApolymerase (Agilent
Technologies, Santa Clara, CA) or TaqDNA polymerase with Thermopol
buffer (New England BioLabs) was used in PCRs for strain and plasmid
construction.Oligonucleotides were synthesized by Invitrogen (Carlsbad,
CA) or Integrated DNA Technologies (Coralville, IA) and are listed in
Table 1.
Strain construction. The in-frame markerless deletion of the recN
(EF0984) locus was previously described in an OG1RF(pCF10) strain
(25). The same constructs and procedures were used in this study to gen-
erate a pCF10-free version of OG1RF recN. OG1RF opuBC (EF0675)
was constructed using the previously described allelic exchange method
(30). The deletion construct used for allelic exchange was generated with
overlap-extension PCR by first amplifying two 1-kb fragments from
OG1RF genomicDNAwith primerpairs 0674XbaF/Delta 0675RandDelta
0675 F/0677 R SphI. The two products were annealed together, and second
step amplificationwas performedwithprimers 0674XbaI F and0677RSphI.
The resulting productwas digestedwith enzymesXbaI and SphI, ligated into
pCJK47 (30) predigestedwith the same enzymes, and propagated in E. coli
EC1000 grown on BHI with 100 g/ml erythromycin. Deletion of either
locus had no effect on growth (data not shown).
The OG1RF ahrC-p23ahrCKI strain was generated by allelic ex-
change using pCJK141, a derivative of pCJK47 that facilitates integration
of constructs into the OG1RF chromosome between the convergently
transcribed genes EF1117 and EF1116 (31). The 196-nucleotide intra-
genic region between EF1117 and EF1116 contains a stem-loop transcrip-
tional terminator (32), which has been duplicated in the cloning site of
pCJK141 so that sequences integrated into the chromosome are flanked
by terminators to prevent transcriptional read-through in either direc-
tion. To generate the knock-in p23 construct, the ahrC gene—including its
native ribosome binding site (RBS)—was PCR amplified from OG1RF
genomic DNA using primer pair 0983 RBS BamHI F/0983 st cod NcoI R,
and ligated into pCJK141 at the BamHI and NcoI restriction sites in the
multiple cloning site of the vector. A PCR product containing the p23
promoter, originally from Lactococcus sp. (33), was generated with primer
pair NotI P23/BamHI P23 and was introduced upstream of ahrC in
pCJK141 at the NotI and BamHI restriction sites.
Rabbit model of experimental endocarditis. Endocarditis infections
were carried out as previously described (34). Briefly, one to three colonies
of each strain were inoculated into BH medium and grown overnight.
Cultures of OG1RFahrCahrC also contained 10g/ml erythromycin
and 25 ng/ml nisin. Cells were pelleted and resuspended to an optical
density at 600 nm (OD600) of 1.0 in potassium phosphate-buffered saline
(KPBS), corresponding to2 109 to 4 109 CFU/ml. Following sur-
Enterococcus faecalis Bioﬁlm Infection
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gery to mechanically damage the aortic valve (34), 2 ml was administered
intravenously via the marginal ear vein to initiate infection. Rabbits were
euthanized 4 days after infection, and the hearts were removed and dis-
sected to expose the aortic valve. Vegetations and valve leaflets were har-
vested, weighed, homogenized in 1 ml of Todd-Hewitt broth (THB) or
KPBS, serially diluted, and plated on BHI agar to quantify bacteria. Ho-
mogenates from animals infected with OG1RF ahrCahrC were also
plated on BHI agar containing 10 g/ml erythromycin to determine the
percentage of cells that retained the complementation vector for the du-
ration of the infection.
Endocarditis results were analyzed for statistical significancewith one-
way analysis of variance (ANOVA), followed by Bonferroni’s multiple
comparison tests in GraphPad Prism (version 5.04; GraphPad Software,
Inc., La Jolla, CA).
Murine model of CAUTI.OG1RF, OG1RFahrC, and OG1RF eep
were tested in a mouse model of catheter-associated urinary tract infec-
tion (CAUTI) as previously described (12). Briefly, 1  107 bacteria
were inoculated into C57BL/6Ncr female mice that had silicone catheter
pieces implanted in their bladders. Eight to 10 mice were infected per
strain. Animalswere euthanized 24 hpostinfection by cervical dislocation,
and then catheter implants, bladders, and kidney pairs were harvested.
Bacterial counts from implants, bladders, and kidney pairs were obtained
as previously described (12). The limits of detection (LOD) were 20 CFU
per implant and 40CFUper bladder or pair of kidneys. Implants or organs
with bacterial counts below the LOD were assigned the LOD value for
statistical calculations. The experiment was repeated once, and the results
were pooled. Only mice from which implants were recovered at the time
of sacrifice were included in the final analysis. The Mann-Whitney U test
in GraphPad Prism was used to assess statistical significance.
Microtiter plate biofilm assay. Microtiter plate biofilm assays were
based on a previously described protocol, with minor changes (35).
Briefly, three colonies per strain were inoculated into 2-ml BHI cultures
and grown overnight. Cultures were diluted 1:100 in TSB-dex, and 100 l
of each diluted strain was pipetted into 8 wells of a 96-well plate (Costar
3595; Corning, Inc., Corning, NY). All cultures of OG1RFahrCahrC
also contained 10 g/ml erythromycin and 25 ng/ml nisin. Wells with
sterile medium were used as blanks. Plates were statically incubated at
37°C for 6 or 24 h in a humid container. Culture turbidity was assessed
following incubation by reading the optical density at 600 nm (OD600) on
aModulusmicroplate multimode reader (Turner Biosystems, Sunnyvale,
CA). The medium was removed, wells were washed three times with 100
l water, and plates were dried in an inverted position for at least 4 h.
Wells were stained with 100 l of 0.1% safranin for 20 min, and then the
stain was removed and wells were washed five times with water and dried
for at least 4 h. The safranin stain was quantified by reading the optical
density of dried wells at 450 nm. Three to six biological replicates were
performed for each strain. The OD450 values for all biological replicates
were averaged together and reported as percent biofilm formation relative
to OG1RF, which was set to 100%.
Biofilm microscopy. E. faecalis OG1RF and ahrC biofilms were in-
oculated at a 1:50 dilution from overnight cultures and grown on Aclar
fluoropolymer coupons for 6 h and washed for imaging as previously
described (13). Coupons were stained with an Alexa Fluor 594-wheat
germ agglutinin conjugate (Invitrogen) and fixed in 2% methanol-free
formaldehyde with 6% sucrose added to avoid hypoosmolality. Coupons
were rinsed in PBS and mounted in Vectashield Hardset (Vector Labora-
tories, Burlingame, CA) with coverslip spacers to avoid mechanical com-
pression of the biofilm. Biofilm imaging was done using a 20 0.75 NA
TABLE 1 Enterococcus faecalis strains and oligonucleotides used in this study
Strain or oligonucleotide Strain description or oligonucleotide sequence Source or reference
Strains
OG1RF Wild-type strain 60
OG1RF opuBC Markerless in-frame deletion of locus EF0675 This study
OG1RF recN Markerless in-frame deletion of locus EF0984, remade in a pCF10-free background in this study 25; this study
OG1RF eep Markerless in-frame deletion of locus EF2380, also called JRC106 30
OG1RFargR Transposon mutant 17M8, disruption in EF0676 20
OG1RFatlA Transposon mutant 25G5, disruption in EF0799 20
OG1RFahrC Transposon mutant 20K19, disruption in EF0983 20
OG1RFsepF Transposon mutant 30B8, disruption in EF0999 20
OG1RFpyrC Transposon mutant 39F15, disruption in EF1718 20
OG1RFahrCahrC Transposon mutant 20K19 (ahrC) with complementation plasmid pCJK124, a pMSP-3535-based




Transposon mutant 20K19 (ahrC) with ahrC ORF (EF0983) and native RBS fused downstream of
the p23 promoter and integrated into the chromosome between EF1117 and EF1116
This study
Oligonucleotides
0674 XbaI F CTAGTATCTAGAGACAGGTGAAGTGGCTCTCAATGAAC This study
Delta 0675 R GTAAAAAATACTTATTTAAGAAGTGCTTGCATCTACTATCCCTC This study
Delta 0675 F TAGTAGATGCAAGCACTTCTTAAATAAGTATTTTTTACTG This study
0677 R SphI CTAGTAGCATGCGCGTCGTAGCTAAACCAACGTC This study
0983F-RT GAAAAGGGCGTAGCTGTAACAC This study
0983 RBS BamHI F CTGTAGGGATCCGAGTAAACTGAAAAGGAGAGCG This study
0983 st NcoI R CTGTATCCATGGCATTCTTTATAGATAGCTTAACAGC This study
BamHI P23 ATAGTAATAAGCGGCCGCAAAGCCCTGACAACGC This study
NotI P23 GAGTGGATCCTTTTTAATTTAATTCTAAGACTATTTTATC This study
EF0983-F ATGAGAAAGCAAGATAGACACC This study
EF0983-R TTATAGATAGCTTAACAGCTC This study
gelE forward CTTTTTGGGATGGAAAAGCA 39
gelE reverse CCGGCAGTATGTTCCGTTAC 39
gelE ORF-F TCATTCATTGACCAGAACAGA This study
gelE ORF-R ATGAAGGGAAATAAAATTTTATAC This study
Frank et al.
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objective using an electron-multiplying charge-coupled device (EMCCD)
camera (Cascade 1024; Photometrics, Tucson, AZ). Image stacks were
collected at 0.5-m intervals in wide-field immunofluorescence mode
and deconvolved with the Huygens software package (SVI, Hilversum,
The Netherlands). The COMSTAT2 analysis package (36, 37) was used to
provide quantification of the ahrC mutant biomass defect; reported re-
sults are from four independent stacks taken on each of 10 biological
replicates for both the mutant and wild-type strains. Maximum-intensity
projections of the mean image stacks and surface renderings of represen-
tative stacks were also generated (Huygens software package).
Gene expression experiments. For growth curves, overnight cultures
of OG1RF were diluted 1:1,000 into 100 ml of fresh BHI and grown stat-
ically at 37°C. Aliquots were collected at 0, 3.16, 4.1, 5.3, 6.5, and 8.25 h
after inoculation for quantitation by serial dilution and plating. Cells for
RNA extraction were harvested at 3.16 h and all following time points by
measuring the optical density of the culture at 600 nm and then calculat-
ing the volume required to reach the equivalent of 0.6 ml at an OD600 of
1.0. The calculated volume of cells was pelleted, resuspended inKPBS, and
treated with RNAprotect bacterial reagent (Qiagen, Inc., Valencia, CA)
according to themanufacturer’s protocol. Three biological replicateswere
performed. For biofilms, overnight cultures of OG1RF were diluted 1:100
into TSB-dex, and then 3-ml aliquots were placed into 6-well dishes (Co-
star 3516; Corning, Inc.) and shaken at 125 rpm for 6 or 22 h at 37°C.
After incubation, planktonic cells were pooled and aliquots were collected
for cell counts or treated with RNAprotect bacterial reagent for subse-
quent RNA extraction. Biofilms were gently washed twice with 1ml KPBS
and thenmanually removed with a cell scraper into 1ml KPBS, which was
transferred to each successive well in order to pool all biofilms grown in a
single dish. Six wells were pooled for 6-h biofilms, and five wells were
pooled for 22-h biofilms. Due to loss of volume during transfer, the final
volume of pooled cells was adjusted to 1 ml with KPBS. One hundred
microliters was kept for cell counts prior to adding the remainder to
RNAprotect bacterial reagent. Planktonic cells were collected from five
biological replicates. Biofilm cells were collected from six biological rep-
licates.
All cell pellets treated with RNAprotect bacterial reagent were kept
frozen until RNA extraction, which was performed as previously de-
scribed (13). One microgram of each RNA was treated with Turbo
DNA-free (Ambion, Austin, TX) according to the “Rigorous protocol” as
directed by themanufacturer. cDNAwas synthesized from 9l of DNase-
treatedRNAwith randomhexamer primers using the Superscript III first-
strand synthesis system for reverse transcription (RT)-PCR (Invitrogen).
cDNA was diluted 5-fold for growth curve time points and 2-fold for 6-h
planktonic and biofilm samples and was used undiluted for 22-h plank-
tonic and biofilm samples. One microliter of diluted or undiluted cDNA
was used per 25-l reaction mixture with iQ SYBR green Supermix (Bio-
Rad Laboratories, Inc., Hercules, CA) and 10 M each primer. Reaction
mixtures containing 12 ng of DNase-treated RNA were prepared to
confirm successful removal of contaminating DNA. Quantitative PCR
(qPCR) was carried out on an iQ5 iCycler real-time detection system
(Bio-Rad). Each reaction was performed in triplicate, and threshold cycle
values were averaged.
Primers used in qPCR and for generating copy number standards are
listed in Table 1. Absolute quantification of transcript copy number was
calculated by interpolating threshold cycle values against standard curves,
as described previously for Staphylococcus aureus (38). To prepare the
standard curves, the gelE and ahrC genes were PCR amplified in standard
PCRs using Taq polymerase with primer pairs gelE ORF-F/gelE ORF-R
and EF0983-F/EF0983-R, respectively. PCR products were ligated into
pGEM-T Easy (Promega Corp., Madison, WI) and propagated in E. coli
DH5 on LB containing 50 g/ml carbenicillin. Ten-fold dilutions of
plasmidDNApreparedwith theQIAprep spinminiprep kit (Qiagen, Inc.)
were used as the templates in qPCR standard curve amplification reac-
tions. For cDNAs that were diluted prior to qPCR, copy numbers were
multiplied by the dilution factor to calculate the copy number per l of
undiluted cDNA. Since unequal numbers of cells were harvested from
planktonic/biofilm experiments, the relative gene expression was calcu-
lated by dividing the copy number per l of cDNA by the corresponding
CFU/ml count.
Recombinant His-tagged AhrC purification, antisera, andWestern
blots. The ahrC gene, including its native ribosome binding site, was PCR
amplified and ligated into the pET28b() expression vector (EMD Mil-
lipore Corporation, Billerica, MA). The resulting plasmid was used to
express and purify the recombinant His-tagged protein in E. coli BL21
cells under the growth conditions used for the purification of other E.
faecalis proteins (39). Briefly, an overnight culture of BL21 carrying the
expression vector was diluted 1:100 into LB containing 50 g/ml kana-
mycin and shaken at 30°C until cells reached an OD600 of 0.7. IPTG (iso-
propyl-	-D-thiogalactopyranoside) was added to a final concentration of
1 mM, and the cells were incubated for 4 h. Protein was purified as previ-
ously described (40) and eluted in buffer containing 200 mM imidazole,
30mMTris-HCl (pH7.5), 0.5MNaCl, and 10%glycerol. The proteinwas
dialyzed overnight at 4°C in elution buffer lacking imidazole.
Polyclonal antisera against recombinant AhrC protein was generated
in a NewZealandWhite rabbit using standard procedures. The rabbit was
immunized three times at 2-week intervals with 10 g purified recombi-
nant His-tagged AhrC per injection.
Cultures of M9-YE inoculated with three colonies of OG1RF, OG1RF
ahrC, or OG1RF ahrC-p23ahrCKI were grown overnight at 37°C and
then diluted 1:10 or 1:100 and grown for 2more hours.Whole-cell lysates
were prepared from aliquots of cells harvested from overnight (station-
ary) or 2-h (exponential) cultures normalized to an OD600 of 1. Pelleted
bacteria were resuspended in TES buffer (10 mM Tris [pH 8.0], 1 mM
EDTA [pH 8.0], 25% sucrose) containing 15 mg/ml lysozyme and incu-
bated at 37°C for 15 min. Cell lysis supernatants were subjected to SDS-
polyacrylamide gel electrophoresis using standard protocols. Separated
proteins were transferred to nitrocellulose membranes, which were
blocked overnight with 10%milk in KPBS–0.1% Tween 20 at 4°C. Mem-
branes were probed at room temperature for 1 to 2 h with a 1:4,000
dilution of the polyclonal anti-AhrC antiserum in blocking solution,
washed with KPBS–0.1% Tween 20, and secondarily probed with a
1:5,000 dilution of horseradish peroxidase (HRP)-goat antirabbit IgG
(HL) antibody (Zymed; Invitrogen) in blocking solution for 1 to 2.5 h.
Washed membranes were treated with the SuperSignal West Pico chemi-
luminescent substrate kit (Thermo Scientific, Rockford, IL) according to
the manufacturer’s instructions and exposed to film or a chemilumines-
cent imaging documentation system to detect signals. Two to three bio-
logical replicates were performed for each strain. Band densitometry was
performed with ImageJ software (version 1.46r).
RESULTS
Biofilm-associated mutants tested in this study. To test the hy-
pothesis that enterococcal biofilm determinants are virulence fac-
tors in endocarditis, we chose seven loci (Table 1) in the chromo-
some of E. faecalis OG1RF that were associated with biofilm
formation in our previous studies (20, 25). The following five loci
were disrupted with transposon insertions: EF0676, EF0799,
EF0983, EF0999, and EF1718. The other two loci, EF0675 and
EF0984, were removed from the chromosome as in-frame dele-
tions generated by allelic exchange. Aside from EF0799, the func-
tions of the selected loci in enterococcal biofilm formation or vir-
ulence have not been characterized. EF0799, which encodes the
autolysin AtlA (also called Atn), has biofilm-associated functions
(23, 41) but does not contribute to virulence in peritonitis or UTI
models (12, 24). The phenotype of an atlA-deficient strain in en-
docarditis has not been reported previously.
EF0984 and EF1718 are annotated in the E. faecalis V583 ge-
nome sequence available through the J. Craig Venter Institute
(JCVI) as encoding the highly conserved orthologs of DNA repair
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protein RecN (recN gene) and dihydroorotase (pyrC gene), re-
spectively. Gene assignments for the remaining loci were made
based on amino acid sequence homologies (Table 2). EF0675 en-
codes a glycine betaine/choline-binding protein of an ABC-type
transporter that is highly similar to the opuBC gene annotated in
Streptococcus mutans; we have designated EF0675 as the opuBC
ortholog of E. faecalis. EF0999 is annotated as a conserved hypo-
thetical protein in strain V583 and a hypothetical protein in the E.
faecalis OG1RF genome sequence (GenBank accession no.
CP002621.1) housed at the National Center for Biotechnology
Information (NCBI), but contains a conserved region of homol-
ogy in its C-terminal half that is found in the sepF loci of other
Gram-positive microbes. Thus, we have designated EF0999 as the
sepF ortholog (also called ylmF) in E. faecalisOG1RF. SepF/YlmF
has been shown to associate with FtsZ during cell division in Ba-
cillus subtilis (42, 43).
The loci disrupted in transposon insertion mutants EF0676
and EF0983 encode related ArgR/AhrC family transcriptional
regulators. As indicated in Table 2, the amino acid sequence of
EF0676 ismost similar toArgRofLactococcus lactis subsp. cremoris
MG1363, while that of EF0983 ismost similar to AhrC of the same
Lactococcus strain (44). In addition, EF0983 is adjacent to the open
reading frame (ORF) encoding recN, which is a conserved
genomic organization found in otherGram-positive bacteria (45).
EF0676 is annotated as the arginine repressor argR in theE. faecalis
V583 genome sequence at JCVI, but was generically assigned the
gene symbol argR2 (locus OG1RF_10413) in the OG1RF genome
at NCBI. Likewise, EF0983 has been assigned the gene symbol
argR3 (locus OG1RF_10717) in the NCBI OG1RF genome anno-
tation. There are two additional ArgR-like transcription factors in
the OG1RF genome, encoded by the adjacent, but divergent, loci
EF0102 and EF0103. These genes lie immediately upstream of the
arginine catabolism genes and were referred to as argR2 and
argR1, respectively, in an older study (46). Due to the high se-
quence homology and conserved genome organization with spe-
cies in which these genes have been characterized, we believe the
most accurate gene names for EF0676 and EF0983 are argR and
ahrC, respectively, and refer to them as such herein.
Characterization of the role of biofilm determinants in early
biofilm biomass accumulation. The transposon mutants chosen
for this study were previously shown to be deficient for biofilm
formation using a microtiter plate biofilm assay that primarily
evaluates initial attachment and early biomass accumulation (20).
The time points at which the transposon strains’ defects affect
biofilm formation prior to the 24-h assay endpoint are not known.
In addition, the phenotypes of the two in-frame deletion mutants
(Table 1) in the microtiter plate biofilm assay are unknown. This
led us to test the seven strains for biofilm formation at 6 and 24 h.
Defects in biofilm biomass accumulation by the transposon
mutants at 24 h (Fig. 1) were consistent with our previous results
(20), except that thesepF strain produced more biofilm than in
our previous report (20). At 6 h, the biofilm biomass value for
sepFwas only slightly lower than the same value forOG1RF (Fig.
1). The biofilm biomasses of the other four transposon mutants
fell below the line at 75% biofilm biomass relative to OG1RF,
which was the level we previously used to define reduced biofilm
formation (20). The early biofilmdefect wasmost pronounced for
the argR and ahrC transcription factor mutants, suggesting
these strains are deficient in initial attachment in this experimen-
tal system. The early biofilm defect was fully restored (Fig. 1) by
expression of the ahrCORF from both an inducible promoter on
a plasmid, as was previously shown for 24-h biofilms (20), and the
constitutive lactococcal p23 promoter integrated into the chromo-
some at an ectopic site (described further below).
The opuBC and recN strains both produced biofilms at
TABLE 2 Gene assignments based on amino acid homology for previously unassigned E. faecalis loci tested in this study
Locus Gene name Gene function
BLASTP % identity/similarity,
organism
NCBI accession no. for
sequence used in
BLASTP alignment
EF0675 opuBC Glycine betaine/choline-binding protein
of an ABC-type transporter
62/80, Streptococcus mutans NP_721486.1
EF0676 argR Transcriptional regulator 34/60, Lactococcus lactis subsp. cremoris AAR99639.1
EF0983 ahrC Transcriptional regulator 36/56, Lactococcus lactis subsp. cremoris AAR99642.1
EF0999 sepF Cell division protein 52/75,a Bacillus subtilis NP_389422.2
a Homology based on amino acids 123 to 207 of the EF0999 protein sequence.
FIG 1 Characterization of the role of biofilm determinants in biofilm biomass
accumulation at 6 and 24 h. Biofilm biomass accumulation after 6 (black bars)
and 24 (white bars) h in a microtiter plate biofilm assay was measured for E.
faecalis wild-type strain OG1RF and seven strains with either mariner trans-
poson insertions (designated by in the strain name) or in-frame markerless
deletions (designated by  in the strain name) in previously identified biofilm
determinant genes (20, 25). TheahrCahrC strain carries plasmid pCJK124
(20), a pMSP3535-based vector with the ahrC open reading frame cloned
downstream of a nisin-inducible promoter. The ahrCp23ahrCKI strain
constitutively expresses the ahrC open reading frame from the p23 promoter at
an ectopic chromosomal location, as described in the text. The mean absor-
bance for n 
 2 to 6 biological replicates per strain is graphed as percent
biofilm biomass relative to OG1RF, which was set to 100%. Error bars repre-
sent standard deviations (SD). The mean absorbances SD for OG1RF were
0.092 0.012 for 6 h and 0.126 0.010 for 24 h (n
 6 for both time points).
The dotted line at 75% represents the level used to define reduced biofilm
accumulation in our previous genetic screen for biofilm-defective transposon
insertion mutants (20).
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near-wild-type levels at 24 h (data not shown). These results are
consistent with the biofilm formation phenotypes of three other
in-frame deletion strains, including eep, that were characterized
subsequent to the corresponding genes being identified in our
previous RIVET studies (13). At 6 h, biofilm formation for the
opuBC andrecN strains was equivalent to that of the wild type.
Theeep strain, which was included in Fig. 1 for comparison, also
showed no early biofilm formation defects in the microtiter plate
biofilm assay (13).
Role of biofilm determinants in endocarditis virulence. We
next evaluated the seven strains for virulence in a rabbit model of
endocarditis, as measured by the bacterial load recovered from
harvested valve leaflets and vegetations that formed after 4 days of
infection (Fig. 2). Initial infections using 3 to 5 animals per strain
were carried out in order to determine whether any strains re-
tained wild-type virulence levels. Those lacking discernible de-
creases in valve bacterial loads after initial testing were not used in
additional infection experiments, and the data from the initial
tests are shown in Fig. 2. Strains that showed reduced bacterial
loads were tested in additional animals, as indicated in Fig. 2. The
mean valve bacterial loads of the atlA and pyrC strains were
slightly higher than that for OG1RF. The opuBC,argR, recN,
andsepF strains had mean valve bacterial loads that were 1 to 2
log10 CFU lower than that for OG1RF. These values were not
found to be significantly different from those for OG1RF in a
statistical analysis. The ahrC mutant mean valve bacterial load
was significantly reduced compared to that of OG1RF. Interest-
ingly, three in-frame deletion mutants, the ebrA, proB, and
eep strains, which we previously tested in the samemodel system
(13), showed a similar spread of mean valve bacterial loads (indi-
cated in Fig. 2). Valve bacterial loads for the ahrC and eep
strains were both reduced by more than 4 log10 CFU compared to
OG1RF (P 0.05). Of the 10 total strains with mutations in bio-
film-associated genes evaluated between this study and our previ-
ous work, the ahrC and eep strains both had altered in vitro
biofilm formation phenotypes (Fig. 1) (13) and were the most
highly attenuated in endocarditis. These results show that certain
enterococcal biofilm-associated genes are also important for vir-
ulence in a biofilm-associated infection.
As we previously demonstrated with the eep mutant strain
(13), expression of the ahrCORF from an inducible promoter on
a plasmid enhanced theahrC endocarditis virulence phenotype
(Fig. 2). The mean valve bacterial load of the complementation
strain was 1.6 log10 CFU lower than that of OG1RF. This may be
due in part to the lack of inducing agent required for maximal
continued expression of the ORF and the absence of antibiotic
selection required for plasmid maintenance in the host environ-
ment. Indeed, the complementation plasmid was only retained in
2.6%  3.3% (mean  standard deviation [SD]) of cells by the
end of the 4-day infection. These data are consistent with a model
in which the functional role of AhrC in endocarditis occurs pri-
marily during the early stages of infection. In light of the instability
of the complementation plasmid, we generated a derivative of the
ahrC strain in which the ahrC ORF was integrated in the chro-
mosome in single copy and expressed under the control of the
constitutive lactococcal p23 promoter (33). When this strain was
tested in endocarditis (Fig. 2), we were surprised to find that the
strain was as attenuated asahrC. Based on these results, we sus-
pect that temporal regulation of the wild-type ahrC locus is nec-
essary for virulence. Comparative analysis of ahrC expression
from the wild-type and p23 promoters is presented below.
Evaluation of biofilm-associated endocarditis virulence fac-
tors in an experimental model of CAUTI. To test if ahrC and eep
are important for virulence in a nonendocarditis biofilm infection
model, we tested the two mutant strains in a recently established
mousemodel of enterococcal CAUTI (12). Bacterial counts deter-
mined from the bladders, kidneys, and catheter implants of mice
after 24 h of infection are shown in Fig. 3. OG1RFwas recovered at
106 CFU from implants and bladders and 104 CFU from the
kidneys. The CFU levels of the eepmutant recovered from blad-
ders were similar to those of OG1RF, while the levels recovered
from implant surfaces were more variable. The medianeepCFU
counts from homogenized kidneys were 1 log lower than the
OG1RF kidney CFU counts, which was a statistically significant
difference; no bacteria were recovered for three animals in this
cohort. ahrC CFU counts were reduced by statistically signifi-
cant amounts in the bladder and kidneys and on the implants.
ahrC was particularly defective in colonizing the kidneys, as
CFU counts were above the limit of detection in only 5 of 14 mice
(36%). The outcome of the CAUTI experiments indicates that
ahrC, and to a lesser extent, eep, are also important for uroviru-
lence.
Microscopic characterization of early-time-point ahrC
biofilms. Since ahrC is an important contributor to the virulence
of two biofilm-associated infections, we used immunofluores-
cence microscopy to study the mutant strain’s biofilm defect in
detail. The maximum intensity projections of mean image stacks
obtained frombiofilms ofOG1RF and theahrC strain grown for
6 h, which are shown in Fig. 4, demonstrate a significant defect in
ahrC strain biomass (Fig. 4A) compared to that of a matched
OG1RF sample (Fig. 4B). Themean biomass difference is approx-
imately 4-fold via quantitative COMSTAT2 analysis (data not
shown) (P
 0.001 by Student’s t test). TheahrC defect was even
more visually pronouncedwhen themicroscopy data were viewed
FIG 2 Role of biofilm determinants in experimental endocarditis virulence.
Aortic valve leaflets and vegetations from rabbits in which E. faecalis endocar-
ditis had been inducedwere harvested, homogenized, and plated to enumerate
bacteria at 4 days postinoculation. Each symbol represents the log10 valve
bacterial load for an individual animal. Thick horizontal bars show the arith-
metic mean of the log10-transformed values. For comparison, the arithmetic
mean log10 valve bacterial loads for the ebrA, proB, and eep strains tested
in the same experimental endocarditis model in a previous study (13) are
shown at the far right (thin horizontal bars). OG1RF, n
 8; opuBC, n
 6;
argR, n 
 5; atlA, n 
 3; ahrC, n 
 6; ahrCahrC, n 
 9; ahrC-
p23ahrCKI, n
 5; recN, n
 6;sepF, n
 6;pyrC, n
 5. ##, P 0.05 by
one-way ANOVA followed by Bonferroni’s multiple comparison test.
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as surface projections (Fig. 4C and D): in addition to the overall
biomass defect (Fig. 4C), 6-hahrC strain biofilms failed to pro-
duce mature microcolonies compared to OG1RF biofilms
(Fig. 4D).
ahrC is maximally expressed during exponential phase. We
characterized expression of the ahrC locus during batch-phase
growth and in biofilms to investigate further the idea that this gene
is involved in early steps of biofilm formation and the pathogen-
esis of biofilm infections. In batch culture, the absolute copy num-
ber of ahrC transcripts was the highest between 3 and 5 h of
growth, which correlated with the exponential growth phase
(Fig. 5A). ahrC transcript copy numbers fell off sharply following
entry into the stationary phase, dropping by 1 log between the 5.3-
and 6.5-h time points. Notably, the expression profile of ahrC is
distinct from that of gelE (Fig. 5A), which encodes the secreted
protease gelatinase that is produced in postexponential phase as a
result of activation of the quorum-sensing fsr gene cluster (47).
The relative levels of expression of ahrC and gelEwere the same
in biofilm cells [average  SD, (8.3  2.7)  108 CFU/ml] and
planktonic cells (2.5 108 8.6 107 CFU/ml) harvested from
the same wells after 6 h of growth (Fig. 5B). Consistent with the
data in Fig. 5A showing a decline in ahrC transcript levels over
time, ahrC transcripts could not be detected in either planktonic
[(6.84.5)108CFU/ml] andbiofilm[(6.02.2)108CFU/ml]
cells after 22hof growth. In contrast, gelE transcriptsweredetected in
planktonic and biofilm cells at 22 h.
Using a polyclonal antiserum raised against recombinant his-
tidine-tagged AhrC, a strong immunoreactive protein band of the
expected size was detected in exponential- and stationary-phase
OG1RF whole-cell lysates, but not in exponential- or stationary-
phase ahrC cell lysates (Fig. 5C). The amount of AhrC in sta-
tionary-phase OG1RF preparations was calculated by densitome-
try to be reduced approximately 25% relative to that in
exponential-phase cells. AhrC was highly overexpressed in
ahrC-p23ahrCKI exponential- and stationary-phase cells com-
pared toOG1RF cells (Fig. 5C), suggesting that the p23 promoter is
much stronger than the native ahrC promoter under the condi-
tions we analyzed.
DISCUSSION
Initial and irreversible attachment of bacteria to surfaces, followed
by biomass accumulation, are the imperative first steps in the pro-
gression of biofilm formation (48). In endocarditis, blood-borne
bacteria attach to host-derived collagen, fibrin, platelets, and oc-
casionally red or white blood cells, to form vegetations at sites of
damaged cardiac endothelium. Similarly, in CAUTI, bacteria in
the urogenital tract interact with host proteins that adhere to the
surfaces of urinary catheters. E. faecalis has many well-studied
surface adhesins that likely facilitate the initial binding phases of
heart valve vegetation formation or urinary catheter colonization,
but other genes must be involved to coordinate the additional
processes, such as extracellular matrix formation, immune eva-
sion, and cell-to-cell communication, that lead to biomass accu-
mulation and the subsequent proliferation of an established bio-
film in vivo. It has been reported that E. faecalis endocarditis
isolatesmakemore biofilm biomass than nonendocarditis isolates
in in vitro assays (27), but no strong linkages have been found
between biofilm formation and the presence of various virulence
factors in endocarditis and other clinical isolates (26, 49). Con-
versely, it has remained largely undefined to this point whether
enterococcal biofilm genetic determinants correlate with viru-
lence functions.
Amajor goal of this studywas to determinewhether gene func-
tion in biofilm formation is predictive of a function in endocardi-
tis virulence. Since bacterial attachment to damaged heart valves is
a critical step in the onset of infection, the majority of the seven
strains we tested had transposon insertions in genes that affected
24-h biofilm formation in an assay that evaluates attachment (20).
Although all of the transposon insertion mutants exhibited re-
duced early biofilm formation relative toOG1RF (Fig. 1), only the
strain with a transposon disruption in the ahrC gene, encoding a
transcriptional regulator, was highly attenuated in the endocardi-
tis model (Fig. 2). AhrC was recently reported to regulate viru-
lence gene expression in the human pathogen Streptococcus pneu-
moniae (45), but it was not tested for a direct role in virulence. The
data presented here represent the first description of AhrC serving
as a virulence factor in any bacterial pathogen.
The two chromosomal in-frame deletion strains, which had
deletions in RIVET-identified genes (25) that were adjacent to
either of the ArgR family transcriptional regulators identified as
biofilm determinants in the transposon screen (20), were not im-
paired in biofilm formation or endocarditis virulence (Fig. 1
and 2, respectively). These data do not support our hypothesis
that the combined results of the transposon and RIVET screens
FIG 3 Enterococcal biofilm determinants important for endocarditis contribute to virulence in an experimental model of CAUTI. The graphs indicate the log10
CFU recovered from retrieved catheter implants (A), homogenized bladders (B), and homogenized kidneys (C) of mice implanted with silicone catheter pieces
and subsequently infected with E. faecalis OG1RF (n 
 12), the eep strain (EF2380; n 
 15), or the ahrC strain (EF0983; n 
 14) for 24 h. Each symbol
represents an individual animal, and only animals from which catheter implants were retrieved were included in the analysis. Horizontal bars represent the
median, and the dashed lines indicate the limits of detection.P values were determinedwith theMann-WhitneyU test: n.s., not significant (P 0.05); *,P
 0.01;
**, P
 0.0003; and ***, P 0.0001.
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reveal transcriptional regulatory networks. The genes deleted
in these strains may have functions in infection or biofilm for-
mation that are redundant with other genetic determinants,
such that their phenotypes are masked in the assays used here.
This precise type of effect has been reported with streptococcal
adhesins (50, 51).
In combination with our previous work (13), we found that
only 2 of the 10 biofilm-associated genes screened in the endocar-
ditis model had significant roles in virulence. Five of the mutants
tested between the two studies demonstrated an intermediate phe-
notype marked by valve bacterial loads that were nonsignificantly
reduced by 1 to 2 log10 CFU relative to OG1RF (Fig. 2). The re-
maining three mutants had the same phenotype as OG1RF. It is
noteworthy that the atlA disruption mutant displayed a wild-type
virulence phenotype in endocarditis, which adds to previously
published evidence that the major autolysin is not specifically rel-
evant in virulence (12, 24), despite the availability of detailed
knowledge about its mechanism in in vitro biofilm formation
(Fig. 6) (20, 23, 41). From these results, we conclude that there is
not a strong association between biofilm formation ability in static
attachment assays and endocarditis virulence. Our group recently
reported that the processes of E. faecalis adherence and biofilm
formation on ex vivo porcine cardiac valves proceed faster than on
cellulose membranes (52). The interactions between bacteria and
the host milieu that occur during in vivo biofilm formation are
substantially more complex than the processes that result in bio-
film formation in standard laboratory assays, such as the microti-
ter plate biofilm assay. The fact that the majority of the mutant
strains tested in our combined studies exhibited either significant
attenuation (n
 2) or had mean valve bacterial loads that were 1
to 2 log10 CFU lower than those of the wild type (n
 5) strongly
indicates that the genetic basis of virulence in the endocarditis
model is multifactorial. Some genes, such as ahrC and eep, are
major contributors to the infection process, while a plethora of
others serve more modest, and possibly functionally redundant,
roles that act together tomaximize the full virulence potential ofE.
faecalis. The absence of any mutants that were wholly unable to
colonize and persist at the heart valve for the duration of a 4-day
infection further supports the hypothesis that full endocarditis
virulence results from the combined functions of multiple genetic
determinants. Although it is impossible to predict how many
genes contribute to endocarditis virulence, the E. faecalis strain
FIG 4 ahrC biofilms display a profound biomass defect in early biofilms. OG1RF and ahrC biofilms were grown on Aclar fluoropolymer coupons for 6 h.
Biofilms were stained with an Alexa Fluor 594-wheat germ agglutinin conjugate and imaged as described inMaterials andMethods. Simple maximum intensity
projections of mean image stacks are shown for theahrC strain (A) and a matched OG1RF sample (B). Biomass stack surface projections of theahrC strain
(C) and OG1RF (D) provide a modicum of depth information to the two-dimensional images. Scale bars, 20 m.
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INY3000 has four mapped Tn916 insertions in its genome and is
avirulent in endocarditis (53–55).
Regardless of the low correlation between in vitro biofilm for-
mation and virulence, this work resulted in the identification of
two virulence factors that are important contributors in two ani-
mal models of biofilm-associated infection (Fig. 6). The eep and
ahrC genes encode proteins that have dramatically different cellu-
lar functions. The in vitro biofilm phenotypes of the eep and
ahrC strains display significantly different phenotypes: under in
vitro conditions, the eep strain makes strong biofilms with an
aberration in cell and matrix distribution (13, 56), while the data
we report here indicate that theahrCmutant is defective in early
attachment (Fig. 1) and biomass accumulation (Fig. 4). Despite
this, disruption of either locus resulted in similar attenuated phe-
notypes in the rabbit endocarditis model (Fig. 2) (13). When as-
sayed in a mouse model of CAUTI (Fig. 3), we found thatahrC
performed far worse in all variables tested thaneep did, although
eep was impaired in kidney colonization relative to OG1RF. A
FIG 5 E. faecalis OG1RF ahrC expression at the RNA and protein levels. (A) Gene expression in batch culture. Aliquots of OG1RF cells growing in BHI were
collected at the indicated time points and processed for quantitation by serial dilution and plating or for RNA extraction. Cell counts (circles connected by dashed
line) correspond to the left y axis. cDNA copy numbers per l for ahrC (squares) and gelE (triangles), included as a control for a gene known to be expressed in
the stationary phase after cells reach an fsr-dependent quorum, correspond with values on the right y axis. Symbols are the mean of n
 3 biological replicates.
Error bars represent standard deviations (SD). (B) Gene expression in biofilms. OG1RF planktonic and biofilm cells grown in plastic dishes in TSB-dex were
harvested for quantitation and RNA extraction after growth for 6 or 22 h. Values are the means SD of n
 5 to 6 biological replicates collected on 2 separate
days. Relative expression of ahrC and gelEwas calculated by dividing the copies of detected transcript perl of cDNA by the corresponding CFU/ml count from
the harvested biofilm cells. b.d., below detectable limit of the qPCR assay. (C) Protein expression in early exponential and stationary phases. Whole-cell lysates
of exponential (E)- or stationary (S)-phase cells were separated by SDS-PAGE, transferred to nitrocellulose, and probed with anti-AhrC polyclonal antisera.
His-tagged AhrC is approximately 18 kDa. The upper band is a cross-reactive protein of unknown identity that was used as a loading control in densitometry
measurements, which revealed that the relative amount of AhrC detected in stationary-phase OG1RF lysates was 25% less than the amount detected in
exponential-phase lysates. Due to the strong overexpression of AhrC in the ahrC-p23ahrCKI strain (labeled “ahrC-KI” on the figure for clarity), a shorter
exposure of the same blot is shown in the bottom image. The top image was adjusted for brightness and contrast after densitometry in order to make the loading
control bands visible for publication.
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major difference between these two models is the presence of a
foreign body in the CAUTI model, while the endocarditis model
involves biofilm formation on a native host surface. The results
from the infection models confirm that the pathogenesis of bio-
film-associated infections differs frommodel tomodel. Given that
only theahrC strain has an in vitro attachment defect, it may be
that the mechanism of attachment employed during in vitro bio-
film formation is also relevant to CAUTI pathogenesis, while
other mechanisms are at play in endocarditis. Overall, these ex-
periments demonstrate that two major enterococcal endocarditis
virulence factors may be more generally classified as virulence
factors of biofilm-associated infections.
Since building a biofilm is a multistep process, the genes that
are involved may act at one or more of the many steps along the
progression of biofilm establishment and maturation (Fig. 6).
This work demonstrates that disabling a strain such that it can no
FIG 6 The biofilm genes ahrC and eep, but not atlA, are also virulence factors in biofilm-associated infections. The steps at which AhrC, AtlA, and Eep contribute
to the process of biofilm formation are indicated (left). The center column illustrates the characterized biofilm phenotypes following disruption of the respective
genes, while the right column summarizes the biofilm-associated infection models (mouse CAUTI or rabbit endocarditis) in which the respective genes
contribute to virulence. The four other genes tested in this study were omitted from this figure because the biofilm phenotypes of strains lacking those genes have
not been characterized in detail. Despite differences in protein function and roles in biofilm formation, AhrC and Eep are both virulence factors of biofilm-
associated infections. The sizes of the mice in the image are scaled to reflect the severity of the attenuation phenotype measured for either ahrC or eep. Further
experimentation is required to determine if the reason why the ahrC gene is a larger contributor than eep to CAUTI virulence is because of its role in the early
biofilm stage of attachment. In contrast to AhrC and Eep, AtlA is important formicrocolony formation during in vitro biofilm formation butmakes no apparent
contribution to E. faecalis virulence.
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longer proceed through these steps may or may not correlate with
adverse effects in establishing a biofilm-related infection. For ex-
ample, loss of AtlA impairs microcolony formation but does not
reduce virulence in biofilm-mediated infections (Fig. 2 and 6)
(12), while deletion of Eep imparts abnormal microcolony cell
and matrix distribution and strongly suppresses vegetation for-
mation during endocarditis and kidney colonization following
CAUTI (Fig. 2, 3, and 6) (13). In the case of ahrC, Fig. 4 shows that
ahrC biofilms lagged behind OG1RF in the accumulation of
stainable biomass after only 6 h of development, which is consis-
tent with the early biofilm attachment defect in the microtiter
plate assay shown in Fig. 1. Expression of ahrC was highest in
planktonic cells during exponential growth of OG1RF (Fig. 5).
Likewise, in the endocarditis complementation experiments using
the nisin-inducible plasmid, ahrC expressionwas likely at itsmax-
imum in the inoculum since nisin was not present following in-
jection of the bacteria into the rabbits. Thus, the data we present
here collectively suggest that ahrC is important in the early stages
of E. faecalis biofilm formation and endocarditis development
(Fig. 6). This contrasts with expression of the gene encoding the
extracellular protease GelE (Fig. 5), which is controlled by the
quorum-sensing fsr locus (47). GelE functions at later stages in
endocarditis by contributing to immune evasion and vegetation
embolization (57).
It is unclear at this point what the specific role of AhrC is in the
virulence of E. faecalis biofilm infections and whether this role is
directly related to its role in in vitro biofilm formation. In other
Gram-positive species, ArgR and AhrC regulate gene expression
in response to arginine (45, 58). The E. faecalis AhrC and ArgR
proteins may have related functions in biofilm formation since
transposon insertions in either gene resulted in the smallest
amount of attachment among the strains tested in early biofilms
(Fig. 1). In preliminary experiments (data not shown), the addi-
tion of arginine to growth medium did not rescue the biofilm-
defective phenotypes of either transposon strain, so it remains
undetermined whether these genes function in response to argi-
nine, as is seen in other species. Based on their disparate pheno-
types in endocarditis virulence, it is clear these two transcription
factors have different regulons within the context of the host en-
vironment. Experiments to characterize the E. faecalisAhrC regu-
lon are needed, as they will provide insight into the regulatory
pathways that function downstream of AhrC in E. faecalis endo-
carditis and in vitro biofilm formation.
The complementation strain that constitutively expresses ahrC
from the chromosome restored the transposon insertion-medi-
ated biofilm defect (Fig. 1), but unexpectedly failed to comple-
ment the endocarditis defect (Fig. 2). While it is possible that
integration of the p23ahrC construct into the chromosome be-
tween genes EF1117 andEF1116 disrupted a regulatory element or
noncoding RNA that is specific for in vivo growth, the presence of
an endogenous stem-loop transcriptional terminator upstream of
the p23ahrC integration site renders this scenario unlikely (32).
We hypothesize that regulated expression of ahrC is critical for its
function in virulence and that gross overproduction of AhrC in
the chromosomal knock-in strain (Fig. 5) disrupted the ability of
E. faecalis to establish infection at the heart valve surface. This
would be the case if AhrC caused repression of genes that mediate
later stages of endocarditis. The reason why overproduction of
AhrCdid not affect biofilm formationmay be due to limitations of
the microtiter plate biofilm assay being unable to segregate the
steps of biofilm formation beyond initial attachment and biomass
generation. Alternatively, it is possible that high constitutive ex-
pression could result in promiscuous binding of the transcription
factor to alternate promoters, resulting in incorrect expression of
genes that affect infection-related functions irrelevant to in vitro
biofilm formation. Further studies are needed to determine how
ahrC expression is controlled. While our data (Fig. 5) confirm
previously published results that the ahrC locus is not positively
regulated by fsr (59), the possibility that transcription of ahrC is
downregulated following fsr activation cannot be ruled out.
In conclusion, this study indicates that two of the biofilm de-
terminants identified from transposon and RIVET genetic screens
are virulence factors contributing to two distinct models of bio-
film-mediated infection. The lack of a major role in endocarditis
virulence for most of the biofilm genes tested here strongly sug-
gests that the genetic requirements for in vitro biofilm formation
and endocarditis do not significantly overlap. Both eep and ahrC
are conserved in Staphylococcus aureus, thus making them attrac-
tive targets for the development of new vaccines or antimicrobial
agents. Determination of the function of these enterococcal bio-
film infection-associated virulence factors in biofilm formation
and the establishment of disease is a source of ongoing study, as is
testing the S. aureus homologs for functions in biofilm formation
and infection. Overall, this research will improve our understand-
ing of the mechanisms used by E. faecalis to colonize and form
biofilms on surfaces inside a host.
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